Clinical diagnosis and management of Alzheimer's disease

Neuroimaging Clinics of North America

Volumn 15, Issue 4, 2005, Pages 767-777

  Husain, Mustafa M ^a   Garrett, Robert K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; DONEPEZIL; GALANTAMINE; KETOCONAZOLE; MEMANTINE; NERVE GROWTH FACTOR; PAROXETINE; PLACEBO; RIVASTIGMINE; SELEGILINE; TAU PROTEIN;

ALZHEIMER DISEASE; AMNESIA; ANOREXIA; BEHAVIOR THERAPY; CAREGIVER SUPPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITIVE DEFECT; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG MECHANISM; DRUG TOLERANCE; HEAD INJURY; HUMAN; LABORATORY TEST; NAUSEA; NEUROFIBRILLARY TANGLE; NEUROSYPHILIS; PRIORITY JOURNAL; RATING SCALE; REVIEW; SENILE DEMENTIA; SENILE PLAQUE; VOMITING; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; HUMANS; MIDDLE AGED;

EID: 31544455281     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2005.09.005     Document Type: Review

References (23)

1. L.E. Hebert Alzheimer's disease in the US population Arch Neurol 60 2003 1119 1122
2. L. Herbert, P. Scherr, and J. Beckett Age specific incidence of Alzheimer's disease in a community population JAMA 273 17 1995 1354 1359
3. Alzheimer's Foundation of America Available at: http://alafdn.org/ alsheimers/cost.shtml
4. L. Fratiglioni Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts Neurology 54 11 Suppl 5 2000 S10 S15
5. E. Larson Survival after initial diagnosis of Alzheimer's disease Ann Intern Med 140 2004 501 509
6. C. Clark Alzheimer's disease: current concepts and emerging diagnostic and therapeutic strategies Ann Intern Med 138 2003 400 410
7. Diagnostic and statistical manual of mental disorders 4th edition 2000 Text revision. American Psychiatric Association
8. D. Knopman, S. Dekosky, and J. Cummings Report of the Quality Standards Subcommittee of the American Academy of Neurology: practice parameter: diagnosis of dementia (an evidence-based review) Neurology 56 2001 1143 1153
9. A.M. Clarfield Arch Intern Med 163 2003 2219 2229
10. C.W. Ritchie, D. Ames, and T. Clayton Meta-analysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease Am J Geriatr Psychiatry 12 4 2004 358 369
11. D.S. Geldmacher, G.P. Provenzano, and T. McRae Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease J Am Geriatr Soc 51 2003 937 944
12. C. Courtney, D. Farrell, and R. Gray Long-term donepezil treatment in 565 patients with Alzheimer's disease Lancet 363 9427 2004 2105 2115
13. R. Doody, D. Geldmacher, and B. Gordon Open label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer's disease Arch Neurol 58 2001 427 433
14. M. Sano, C. Ernesto, and R. Thomas A controlled trial of selegiline, alpha-tocopherol or both as treatment for Alzheimers disease N Engl J Med 336 17 1997 1216 1222
15. S. Shumaker, C. Legault, and S. Rap Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in the postmenopausal women JAMA 289 2003 2651 2662
16. J. Cummings Alzheimer's disease N Engl J Med 351 2004 56 65
17. M. Tuszynski, L. Thal, and M. Pay A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Nature Medicine 11 2005 551 555
18. J. Orgogozo, S. Gilman, and J. Dartigues Subacute meningoencephalitis in a subset of patients with AD after AB42 immunization Neurology 61 2003 46 54
19. C. Hock, U. Konietzko, and J.R. Streffer Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease Neuron 38 4 2003 547 554
20. D.G. Lysketosos, O. Lopes, and B. Jones Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study JAMA 288 2002 1475 1483
21. N. Trinh Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer's disease JAMA 289 2003 210 216
22. FDA. Public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. April 4, 2005
23. L. Schneider, M. Ismail, and S. Dagerman Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial Schizophrenia Bulletin 29 1 2003 57 72